Literature DB >> 20128035

Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase.

Mao-Lin Yan1, Yao-Dong Wang, Yi-Feng Tian, Zhi-De Lai, Lv-Nan Yan.   

Abstract

AIM: To explore the possibility and mechanism of inhibiting allogeneic T-cell responses by Kupffer cells (KC) pretreated with interferon-gamma (IFN-gamma) in vitro.
METHODS: The expressions of indoleamine 2,3-dioxygenase (IDO) mRNA and FasL mRNA in KC pretreated with IFN-gamma were studied with real-time polymerase chain reaction (PCR). The catabolism of tryptophan by IDO from KC was analyzed by high performance liquid chromatography. Allogeneic T-cell response was used to confirm the inhibition of KC in vitro. The proliferation of lymphocytes was detected using [(3)H] thymidine incorporation. Cell cycle and lymphocyte apoptosis were evaluated by flow cytometric assay.
RESULTS: Real-time PCR revealed IDO mRNA and FasL mRNA expressions in KC pretreated with IFN-gamma, and IDO catabolic effect was confirmed by a decrease in tryptophan and increase in kynurenine concentration. KC expressing IDO and FasL in BABL/c mice acquired the ability to suppress the proliferation of T-cells from C57BL/6, which could be blocked by addition of 1-methyl-tryptophan and anti-FasL antibody. KC expressing IDO could induce allogeneic T-cell apoptosis.
CONCLUSION: In addition to Fas/FasL pathway, IDO may be another mechanism for KC to induce immune tolerance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128035      PMCID: PMC2816279          DOI: 10.3748/wjg.v16.i5.636

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.

Authors:  J M Carlin; E C Borden; P M Sondel; G I Byrne
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

2.  KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.

Authors:  F S Liu; J T Chen; J T Dong; Y T Hsieh; A J Lin; E S Ho; M J Hung; C H Lu
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Authors:  A L Mellor; J Sivakumar; P Chandler; K Smith; H Molina; D Mao; D H Munn
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

4.  T cell apoptosis by tryptophan catabolism.

Authors:  F Fallarino; U Grohmann; C Vacca; R Bianchi; C Orabona; A Spreca; M C Fioretti; P Puccetti
Journal:  Cell Death Differ       Date:  2002-10       Impact factor: 15.828

Review 5.  IDO: a double-edged sword for T(H)1/T(H)2 regulation.

Authors:  Hui Xu; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Immunol Lett       Date:  2008-09-29       Impact factor: 3.685

6.  Hepatic allograft-derived Kupffer cells regulate T cell response in rats.

Authors:  Zhaoli Sun; Tatehiko Wada; Kosei Maemura; Keiichiro Uchikura; Sumito Hoshino; Anna Mae Diehl; Andrew S Klein
Journal:  Liver Transpl       Date:  2003-05       Impact factor: 5.799

7.  Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection.

Authors:  Jerome M Laurence; Chuanmin Wang; Euiyoun T Park; Alexandra Buchanan; Andrew Clouston; Richard D M Allen; Geoffrey W Mccaughan; G Alex Bishop; Alexandra F Sharland
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

8.  Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats.

Authors:  Yong Chen; Zuojin Liu; Shaoyong Liang; Xiaofeng Luan; Feiwu Long; Jie Chen; Yong Peng; Lünan Yan; Jianping Gong
Journal:  Liver Transpl       Date:  2008-06       Impact factor: 5.799

9.  The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.

Authors:  Wei Chen; Xueqing Liang; Amanda J Peterson; David H Munn; Bruce R Blazar
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

10.  Mechanism of T cell tolerance induction by murine hepatic Kupffer cells.

Authors:  Qiang You; Linling Cheng; Ross M Kedl; Cynthia Ju
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

View more
  20 in total

Review 1.  Liver induced transgene tolerance with AAV vectors.

Authors:  Geoffrey D Keeler; David M Markusic; Brad E Hoffman
Journal:  Cell Immunol       Date:  2017-12-05       Impact factor: 4.868

Review 2.  Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.

Authors:  Tim Chan; Robert H Wiltrout; Jonathan M Weiss
Journal:  Int Immunopharmacol       Date:  2011-01-15       Impact factor: 4.932

Review 3.  Deciphering the Dynamic Complexities of the Liver Microenvironment - Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI).

Authors:  Tao Wang; Matthew M Yeh; Mark I Avigan; Lorraine Pelosof; Gerald M Feldman
Journal:  AAPS J       Date:  2021-08-16       Impact factor: 4.009

Review 4.  Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies.

Authors:  Vishnu M Chandra; Luke R Wilkins; David L Brautigan
Journal:  Radiol Imaging Cancer       Date:  2022-07

5.  Immune tolerance in liver disease.

Authors:  Ian N Crispe
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

Review 6.  Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities.

Authors:  Yankai Wen; Joeri Lambrecht; Cynthia Ju; Frank Tacke
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

Review 7.  Modulation of tumor tolerance in primary central nervous system malignancies.

Authors:  Theodore S Johnson; David H Munn; Bernard L Maria
Journal:  Clin Dev Immunol       Date:  2012-01-24

Review 8.  Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies.

Authors:  Cynthia Ju; Frank Tacke
Journal:  Cell Mol Immunol       Date:  2016-02-24       Impact factor: 11.530

Review 9.  NAD+ Metabolism, Metabolic Stress, and Infection.

Authors:  Benjamin Groth; Padmaja Venkatakrishnan; Su-Ju Lin
Journal:  Front Mol Biosci       Date:  2021-05-19

Review 10.  Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests.

Authors:  Vikram Mehraj; Jean-Pierre Routy
Journal:  Int J Tryptophan Res       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.